ZURA
Zura BioCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-23
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
ZURA vs peer average
67/100
ZURA vs. peer average (C vs. D)
Grade spread
B 1 · C 1 · D 5 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
XFOR is the first available peer comparator.
Immunology-focused small-cap biotech with event-driven re-rating around clinical execution and financing risk; closer strategic analogue than broad biotech comps.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ZURA
Zura Bio
XFOR
X4
Grade
C
D
Momentum
85
21
Value
41
41
Sentiment
45
64
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs XFOR
ZURA / XFOR
Grade Position
In line
ZURA vs. peer average (C vs. D)
67/100
Momentum
85
ZURAValue
41
ZURASentiment
45
XFORRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ZURA
XFOR is the first peer returned for this comparison set.

